Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 17 Feb 2023
A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...
Read Full NewsAI models have not outperformed existing clinical scores for COPD prognosis, but home monitoring may help track disease activity, Bourbeau said.
FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia
Williams, MD, is joined by Marcus Gates, MD, and they discuss recognizing cervical nerve root and spinal cord compression, navigating treatment options, and determining when surgery may be appropriate.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 6, 2026.
Two-year data from the phase 2 DAZALS trial showed a lower risk of death with dazucorilant 300 mg/day vs placebo in ALS, although the study did not meet its functional primary end point.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the 2026 AHA/ASA Guideline for Adult Stroke Rehabilitation and Recovery!
Newly presented biomarker and clinical findings from the phase 2b PARADIGM trial of PrimeC informed the design of the global phase 3 PARAGON trial in ALS.
1.
Sydney researchers identify new tools to improve cancer diagnosis and treatment.
2.
Limits to Anti-Nausea Pill Coverage Wear on Cancer Patients and Doctors
3.
Coupling dye and fiducial marking can improve precision in pulmonary nodule surgical resection
4.
More Data from Population-Based Studies Show CRC Screening Lowers Cancer Death Risk.
5.
For treatment, the majority of cancer patients choose complementary therapies.
1.
Unpacking the Importance of White Blood Cells (WBCs) in the Body
2.
Hematopoietic Clonal Competition in Blood Disorders
3.
Prevention Through Preservation of Hematopoietic Reserve During Chronic Physiological Stress
4.
Case-Based Learning: Unexplained Coagulation Abnormality With Normal Platelet Count
5.
Targeted Degradation in Leukemia: Mechanisms, Clinical Implications, and Therapeutic Advances
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
2.
Recognizing Symptoms of Iron Deficiency
3.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
4.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
5.
Signs and Symptoms of Leukemia
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge